Clinical Trial Update: Early Caffeine in Preterm Neonates [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on early caffeine use in preterm neonates for bronchopulmonary dysplasia and apnea of prematurity; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity
• Bronchopulmonary Dysplasia

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: Jennifer Shepherd | Conditions: BPD - Bronchopulmonary Dysplasia, Apnea of Prematurity | Phase 4 | Status: UNKNOWN